Bone Morphogenetic Protein Signaling in Familial Versus Idiopathic Pulmonary Arterial Hypertension.

被引：0
|
作者：
Dewachter, L. [1 ]
Adnot, S. [1 ]
Guignabert, C. [1 ]
Tu, L. [1 ]
Marcos, E. [1 ]
Fadel, E. [2 ]
Humbert, M. [3 ]
Dartevelle, P. [2 ]
Simonneau, G. [3 ]
Naeije, R. [4 ]
Eddahibi, S. [1 ]
机构：
[1] Hop Henri Mondor, INSERM, U841, F-94010 Creteil, France
[2] Hop Marie Lannelongue, F-92350 Le Plessis Robinson, France
[3] Hop Antoine Beclere, INSERM, U764, Clamart, France
[4] Physiol Lab, Brussels, Belgium
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6008
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension A View on the Right Ventricle
    van der Bruggen, Cathelijne E.
    Happe, Chris M.
    Dorfmueller, Peter
    Trip, Pia
    Spruijt, Onno A.
    Rol, Nina
    Hoevenaars, Femke P.
    Houweling, Arjan C.
    Girerd, Barbara
    Marcus, Johannes T.
    Mercier, Olaf
    Humbert, Marc
    Handoko, M. Louis
    van der Velden, Jolanda
    Noordegraaf, Anton Vonk
    Bogaard, Harm Jan
    Goumans, Marie-Jose
    de Man, Frances S.
    CIRCULATION, 2016, 133 (18) : 1747 - +
  • [42] Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension
    Fessel, Joshua P.
    Chen, Xinping
    Frump, Andrea
    Gladson, Santhi
    Blackwell, Tom
    Kang, Christie
    Johnson, Jennifer
    Loyd, James E.
    Hemnes, Anna
    Austin, Eric
    West, James
    PULMONARY CIRCULATION, 2013, 3 (03) : 564 - 577
  • [43] Pharmacological Inhibition of Epidermal Growth Factor Signaling in Experimental Pulmonary Arterial Hypertension.
    Cornitescu, T.
    Dumitrascu, R.
    Dahal, B.
    Pullamsetti, S. S.
    Ghofrani, H. A.
    Weissmann, N.
    Grimminger, F.
    Seeger, W.
    Schermuly, R. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [44] Primary pulmonary hypertension. A familial form.
    Scherpereel, A
    Steenhouwer, F
    Quandalle, P
    Dennetiere, S
    Haftel, Y
    Declercq, N
    Demarcq, JM
    REVUE DES MALADIES RESPIRATOIRES, 1997, 14 (05) : 409 - 412
  • [45] Endovascular Device to Improve Pulmonary Arterial Compliance in Pulmonary Arterial Hypertension.
    Vollmers, Karl
    Scandurra, John
    Gainor, John
    Harder, Lucas
    Weir, Ken
    Pritzker, Marc
    Lang, Irene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B69 - B69
  • [46] A CASE OF UNEVENTFUL THYROIDECTOMY IN IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION. PERIOPERATIVE RISK AND MANAGEMENT.
    Terada, T.
    Kessoku, S.
    Oiwa, A.
    Sato, N.
    Ochiai, R.
    ANESTHESIA AND ANALGESIA, 2016, 123 : 81 - 81
  • [47] Baicalin attenuates monocrotaline-induced pulmonary hypertension through bone morphogenetic protein signaling pathway
    Zhang, Zhaohua
    Zhang, Luan
    Sun, Chao
    Kong, Feng
    Wang, Jue
    Xin, Qian
    Jiang, Wen
    Li, Kaili
    Chen, Ou
    Luan, Yun
    ONCOTARGET, 2017, 8 (38) : 63430 - 63441
  • [48] Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling
    Nickel, Nils P.
    Spiekerkoetter, Edda
    Gu, Mingxia
    Li, Caiyun G.
    Li, Hai
    Kaschwich, Mark
    Diebold, Isabel
    Hennigs, Jan K.
    Kim, Ki-Yoon
    Miyagawa, Kazuya
    Wang, Lingli
    Cao, Aiqin
    Sa, Silin
    Jiang, Xinguo
    Stockstill, Raymond W.
    Nicolls, Mark R.
    Zamanian, Roham T.
    Bland, Richard D.
    Rabinovitch, Marlene
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (11) : 1273 - 1286
  • [49] Idiopathic pulmonary arterial hypertension
    Firth, Amy L.
    Mandel, Jess
    Yuan, Jason X. -J.
    DISEASE MODELS & MECHANISMS, 2010, 3 (5-6) : 268 - 273
  • [50] Idiopathic Pulmonary Arterial Hypertension
    Souza, Rogerio
    Jardim, Carlos
    Humbert, Marc
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (05) : 560 - 567
12345